|
2007
|
HA 14-1
|
Bcl-2 inhibitor and apoptosis inducer of tumor cells |
€75.00 |
|
2390
|
HAMNO
|
Novel protein interaction inhibitor of replication protein A (RPA) |
€85.00 |
|
1645
|
HDAC6 inhibitor ISOX
|
HDAC6 Inhibitor |
€105.00 |
|
2096
|
Hesperadin
|
Reversible and ATP-competitive inhibitor of Aurora B |
€95.00 |
|
1948
|
HIF Phd Inhibitor 4
|
Inhibitor of Hypoxia Inducible Factor PHD |
€105.00 |
|
2034
|
HIF-2 inhibitor 2
|
Allosteric inhibitor of HIF-2 |
€95.00 |
|
2614
|
HIF-2a Translation Inhibitor 76
|
HIF-2a translation inhibitor that works independent of mTOR |
€70.00 |
|
3326
|
HJC0197
|
Potent EPAC antagonist |
€90.00 |
|
2730
|
HJC0350
|
Highly potent and selective EPAC2 antagonist |
€95.00 |
|
2021
|
HL 010183
|
Metformin derivative; AMPK activator |
€135.00 |
|
2710
|
HLCL65 hydrochloride
|
Inhibitor of PRMT5 |
€105.00 |
|
1643
|
HLI 373
|
HDM2 inhibitor |
€95.00 |
|
1616
|
HMR 1031
|
VLA-4 antagonist |
€105.00 |
|
1757
|
HMR 1098
|
K+ channel blocker (SUR1/Kir6.2 selective) |
€90.00 |
|
3064
|
HOIPIN 11a
|
Selective, cell-permeable and covalent inhibitor of RBR E3 ubiquitin ligase HOIP |
€180.00 |